Abortionabortion pillDataEthics and public policy centerFdaFeaturedJosh hawleyMarty MakaryMifepristoneStudyThefederalist.com

FDA Commissioner Faces Pressure To Limit Abortion Pill After Study Finds Increased Risks

[rebelmouse-proxy-image https://thefederalist.com/wp-content/uploads/2025/04/Screenshot-2025-04-29-at-9.01.30 AM-e1745938254545-1200×675.png crop_info=”%7B%22image%22%3A%20%22https%3A//thefederalist.com/wp-content/uploads/2025/04/Screenshot-2025-04-29-at-9.01.30%5Cu202fAM-e1745938254545-1200×675.png%22%7D” expand=1]This isn’t the first time Makary has encountered questions about the status of mifepristone under his leadership.

Source link

Related Posts

1 of 422